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somewhat elusive, in part because of a lack of representative animal models as well as scarcity of in vivo data. Old imaging techniques such as coronary angiography or intravascular ultrasound lack the resolution needed to differentiate plaque rupture from erosion. The relatively recent introduction of optical coherence tomography (OCT), which measures backscattered light, or optical echoes, derived from an infrared light source directed at the arterial wall to generate higher resolution images of the order of 10-15 mM, has been instrumental in furthering our knowledge of in vivo assessment of coronary artery disease. Previous OCT studies of patients with acute coronary syndromes (ACS) showed a 27-31% prevalence of plaque erosion. 3, 4 Although consistent with the aforementioned pathological work, previous OCT studies consisted of a relatively small number of patients. Overall only eight studies have been performed to examine the prevalence of OCT-defined erosion, a total of 790 ACS patients (range 64-139 in each study), with the total number of cases with erosion 267 (range 25-37 in each study). [3] [4] [5] [6] [7] [8] [9] [10] [11] With such a limited number of subjects with plaque erosion, one wonders about their applicability to the real world. In pathological series, patients with plaque erosion (a total of 148 patients) were younger, more likely to be female, have a history of smoking, and have lower cholesterol levels. [11] [12] [13] reported that plaque formation in native coronary bifurcations was significantly higher in low shear stress regions located in the lateral wall vs. high shear stress regions located at the carina. 18 To understand fully the relationship between plaque erosion and shear, we would need to have more information about the percentage stenosis or lumen area in other locations besides the culprit site. These data were not provided. More erosion lesions occurred in the left anterior descending (LAD) artery as compared with ruptures (61% vs. 47%), while the opposite was true for the right coronary artery (RCA) (31% vs. 43%), and lesions in the left cicumflex (LCX) artery were equivalent (8% vs. 10%); P = 0.002. Both erosions and ruptures occur more frequently in the proximal and mid segments of the coronary arteries. Multivessel disease is more common in ruptures than in erosions (50% vs. 30%; P < 0.001). These are all characteristics that were also reported in pathological studies. However, the authors report that initial TIMI flow <1 was more frequent and mural thrombus was greater in ruptures vs. erosions (79% vs. 67%, P = 0.001 and 91 vs. 85%, P = 0.006, respectively). These differences do not reflect what is reported in pathology studies for distal emboli (71% vs. 42%; erosions vs. rupture), which are more frequent, with greater healing of the thrombus seen in erosions than in ruptures (88% vs. 54%; P < 0.0001).
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Take home figure Plaque erosion. (A and B) Plaque erosion with thrombus. There is a lack of disruption of fibrous cap and the thrombus is not in contact with the underlying lipid pool or necrotic core (A and B). Note that both the thrombi are in direct contact with the underlying smooth muscle cell within a proteoglycan-rich matrix (C and E). The underlying plaque shows the presence of a lipid pool (A and D) and a necrotic core with haemorrhage and fragment calcification (B and F). The PIT lesion shows the presence of superficial macrophages while the FA shows the focal presence of macrophages in areas around the necrotic core. Early organization is observed at the thrombus intimal interface, especially in (B). CA, calcium; FA, fibroatheroma; LP, lipid pool; NC, necrotic core; OT, organizing thrombus; PIT, pathological intimal thickening. We also need to discuss briefly the limitations of this study. The concept of OCT-defined erosion is relatively new. OCT-defined erosion is defined and categorized according to the absence of fibrous cap disruption and the presence of thrombus, and divided into definite OCT-defined erosion and probable OCT-defined erosion. 4 First, definite OCT-defined erosion is defined as the presence of a luminal thrombus overlying an intact and visualized plaque. Secondly, probable OCT-defined erosion is defined as (i) luminal surface irregularity at the culprit lesion in the absence of thrombus; or (ii) attenuation of underlying plaque by thrombus without superficial lipid or calcification immediately proximal or distal to the site of the thrombus. 4 The limitations of OCT in this regard must be discussed. OCT cannot distinguish the presence or absence of endothelial cells on the plaque surface, and the presence of luminal thrombus hampers the penetration of light into the underlying plaque, making reliable measurements and diagnosis of the various causes of coronary thrombus difficult. 21 In many of these cases, it is likely that thrombus still remained regardless of the use of an aspiration catheter, and this may have led to a misdiagnosis of erosion. Regarding probable OCT erosion, plaque erosion pathologically is not defined as the absence of lipid or calcification at the culprit site. The reason for this is that the underlying plaque is fibroatheroma, which may include lipid and is not necessarily lacking calcification (Take home figure) . Thus, the accuracy of OCT to identify erosions remains uncertain and must be taken as an important caveat when interpreting this study. Despite these limitations, the data of Dai et al. generally lend credence to the idea that plaque erosion as a disease entity is wholly different from plaque rupture. Fundamental differences in the pathogenesis of thrombosis probably exist, and this raises important questions about the overall topic of therapeutic strategies to prevent coronary artery disease. A substantial number of coronary events result from plaque erosions, yet little is known of how to prevent such events from occurring. While statins are commonly used for primary and secondary prevention of coronary artery disease, does lipid lowering do anything to prevent plaque erosion events? Also, a small study of effective antithrombotic therapy without stenting has shown promise to stabilize plaques and therefore prevent future neoatherosclerosis within stents, thus raising our confidence that innovative therapies are possible in patients with plaque erosion. 22 However, we need to determine in large prospective studies what are the proper preventative treatments for this entity. This and many other questions remain unanswered, but the work of Dai et al. shows that we are making progress in answering some of these questions.
